Ardelyx Inc (ARDX)

[Whalatane]

Cosa. My guess is thats its a 90% probability that the FDA will approve as a combo with the existing binders and probably a 60-70% probability X is also approved as solo use .
The question for me is how fast will the uptake be after approval.
Xphozah will almost certainly require prior authorization ...meaning the MD must certify the patient has failed on the existing generic binders before an insurer will cover. Typically what happens is a patient can't stand Renvela ...so the insurer says ...well try Fosrenol . MD says patient can't tolerate Renvela or Fosrenol ...insurer then says ...Well try Velphoro .
Until all the patient has failed on all the available generics ...then they might OK Xphozah from ARDX.
JMO
Kiwi